Detalles de la búsqueda
1.
Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC).
Prog Urol
; 30(5): 252-260, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32197936
2.
[A patient diagnosed with conversion disorder who did not respond to therapy]. / Een patiënte met de diagnose conversiestoornis die niet verbeterde.
Tijdschr Psychiatr
; 61(10): 725-729, 2019.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-31907917
3.
Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects.
Adv Exp Med Biol
; 867: 93-114, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26530362
4.
Treatment of local-regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors.
Br J Cancer
; 108(10): 1971-7, 2013 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23674085
5.
Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment.
Br J Cancer
; 109(3): 633-40, 2013 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23860533
6.
How Often is Biopsy Necessary in Patients with Prostate Cancer on Active Surveillance?
J Urol
; 195(1): 11-2, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26475660
7.
What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study.
Prostate Cancer Prostatic Dis
; 24(4): 1048-1054, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33833378
8.
A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.
Br J Cancer
; 103(5): 708-14, 2010 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20664589
9.
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer.
Br J Cancer
; 101(11): 1833-8, 2009 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19904272
10.
Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detection.
Clin Chem
; 54(12): 1999-2006, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18927249
11.
Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population.
Prostate Cancer Prostatic Dis
; 20(1): 99-104, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27897172
12.
Pathologic features of prostate cancer found at population-based screening with a four-year interval.
J Natl Cancer Inst
; 93(15): 1153-8, 2001 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11481387
13.
Editorial comment.
J Urol
; 183(3): 950; discussion 950-1, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20083282
14.
Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
J Natl Cancer Inst
; 107(1): 366, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25505238
15.
Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.
J Clin Endocrinol Metab
; 89(9): 4391-6, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15356036
16.
Analytical issues on prostate-specific antigen in relation to prostate cancer screening.
Clin Biochem
; 31(8): 633-9, 1998 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-9876895
17.
Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).
Urol Oncol
; 28(6): 686-90, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21062653
18.
Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer.
Eur J Cancer
; 46(17): 3068-72, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21047588
19.
Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer.
Eur J Cancer
; 46(17): 3082-9, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21047590
20.
PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.
Eur J Cancer
; 46(17): 3053-60, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21047586